Patent classifications
A61B2017/12086
Embolic implant and method of use
A parent artery occlusion (PAO) device which provides for immediate occlusion of a cerebral artery to isolate a defect. The PAO device includes a self-expanding wire-frame prolate structure which is partially covered with an ePTFE membrane.
OCCLUDER, OCCLUDING SYSTEM AND CONVEYING DEVICE
An occluder, an occluding system, and a conveying device are provided. The occluder includes an occluding frame. The occluding frame includes a first occluding unit, a middle portion occluding unit, a second occluding unit, and waist portions. Both ends of the middle portion occluding unit are connected to the first occluding unit and the second occluding unit, respectively, by the waist portions. A fixing member is sleeved on each waist portion. A channel is formed at a middle portion of each fixing member. The occluding frame has an inner cavity. A first opening is formed on the first occluding unit. A second opening is formed on the second occluding unit. The first opening, the channel, the inner cavity, and the second opening are communicated to form a path. A locking member can be omitted in the occluder.
Delivery and detachment mechanisms for vascular implants
Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.
METHODS AND APPARATUS FOR OCCLUDING THE LEFT ATRIAL APPENDAGE
A device for occluding a patient's left atrial appendage (LAA) device includes a self-expanding closure disc and an anchor. The self-expanding closure disc has an atrial side, an appendage side, and a peripheral edge configured to engage tissue on both an atrial side and an appendage side of an opening between the left atrium and the left atrial appendage. The self-expanding anchor extends from the appendage side of the self-expanding closure disc, and an annular sealing skirt extends about at least a portion of the appendage side of the self-expanding closure disc. the annular sealing skirt is more compliant than the self-expanding closure disc to seal over the left appendage side of the opening after implantation of the device in the LAA.
LEFT ATRIAL APPENDAGE OCCLUSION DEVICE DELIVERY SYSTEM
In various embodiments, a system for delivering an implantable device inside a body cavity includes: 1) a core cannula; 2) an access sheath; 3) an injection apparatus for filling the implantable device with one or more fluids; and 4) expanding members operatively connected to the core cannula for preventing the core cannula from advancing through a body orifice once the core cannula and expanding members exist the access sheath. According to particular embodiments, a distal end of the core cannula is pre-attached to the implantable device through a device locking member. In one or more embodiments, upon assessment, an injection apparatus is removed using an injection apparatus handle, the implantable device is detached from the core cannula via a device deployment handle (to be implanted), and the access sheath is removed.
IMPLANT DELIVERY SYSTEMS AND METHODS
The present teachings provide a medical system for delivering and deploying a medical implant, and the method of using thereof. Specifically, one aspect of the present teachings provides a medical system having an implant with an engagement loop, and a delivery system having an engagement wire and an interface. During implant delivery, the engagement wire engages the engagement loop of the implant. The engagement wire further interacts with the interface in order to prevent unintended disengagement of the engagement loop from the engagement wire. Certain embodiment of the present teaching also includes an implant release control mechanism fixedly attaching to a proximal end of the engagement wire. During implant delivery, the implant release control mechanism attaches the proximal end of the delivery system. During implant deployment, the implant release control mechanism detaches the proximal end of the delivery system.
Methods and devices for controlling the size of emphysematous bullae
An implantable device for control over the size of emphysematous bullae in a lung, including: an elongated central region having a fixed axial length; a first end including a first anchor; and a second end including a second anchor.
Implant delivery systems and methods
The present teachings provide a medical system for delivering and deploying a medical implant, and the method of using thereof. Specifically, one aspect of the present teachings provides a medical system having an implant with an engagement loop, and a delivery system having an engagement wire and an interface. During implant delivery, the engagement wire engages the engagement loop of the implant. The engagement wire further interacts with the interface in order to prevent unintended disengagement of the engagement loop from the engagement wire. Certain embodiment of the present teaching also includes an implant release control mechanism fixedly attaching to a proximal end of the engagement wire. During implant delivery, the implant release control mechanism attaches the proximal end of the delivery system. During implant deployment, the implant release control mechanism detaches the proximal end of the delivery system.
Left atrial appendage occlusion device delivery system
In various embodiments, a system for delivering an implantable device inside a body cavity includes: 1) a core cannula; 2) an access sheath; 3) an injection apparatus for filling the implantable device with one or more fluids; and 4) expanding members operatively connected to the core cannula for preventing the core cannula from advancing through a body orifice once the core cannula and expanding members exist the access sheath. According to particular embodiments, a distal end of the core cannula is pre-attached to the implantable device through a device locking member. In one or more embodiments, upon assessment, an injection apparatus is removed using an injection apparatus handle, the implantable device is detached from the core cannula via a device deployment handle (to be implanted), and the access sheath is removed.
DELIVERY AND DETACHMENT MECHANISMS FOR VASCULAR IMPLANTS
Vascular delivery systems configured to deliver an implant to a location within a vasculature can include one or more control wires controllable by a user to detach the implant from the delivery system. Control wires can cause a feature of the delivery system to mechanically engage a hub at a proximal end of an implant. Proximal or distal movement of the control wire can allow the feature to disengage from the hub, thereby allowing release of the implant.